United Kingdom· GB-APID-36877711000001107
Delstrigo 100mg/300mg/245mg tablets
A lamivudine, tenofovir disoproxil and doravirine product containing doravirine + lamivudine + tenofovir disoproxil, registered in United Kingdom by Merck Sharp & Dohme (UK) Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Lamivudine, tenofovir disoproxil and doravirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR24 (lamivudine, tenofovir disoproxil and doravirine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Lamivudine, tenofovir disoproxil and doravirine · ATC J05AR24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Doravirine + Lamivudine + Tenofovir disoproxil
- Manufacturer
- Merck Sharp & Dohme (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AR24
- ATC class
- Lamivudine, tenofovir disoproxil and doravirine
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin00191778021004
- gtin5013945304350
- gtin00191778021196
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine, tenofovir disoproxil and doravirine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDELSTRIGOMerck Sharp & Dohme B.V., Haarlem
- FinlandDelstrigoMerck Sharp & Dohme B.V.
- United StatesDELSTRIGOMerck Sharp & Dohme LLC
- CanadaDELSTRIGOMERCK CANADA INC
- IcelandDelstrigoMerck Sharp & Dohme B.V.*
- NorwayDelstrigoMerck Sharp & Dohme Ltd (1)
- PolandDelstrigoMerck Sharp & Dohme B.V.
- SwedenDelstrigo 100 mg/300 mg/245 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Delstrigo
- Liechtenstein · Delstrigo
- Norway · Delstrigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/64118b7d-d830-4ece-8ced-8bf0ebfee3fe GET /v1/drugs/64118b7d-d830-4ece-8ced-8bf0ebfee3fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36877711000001107",
"desc": "Delstrigo 100mg/300mg/245mg tablets (Merck Sharp & Dohme (UK) Ltd)",
"form": "Oral tablet",
"vpid": "36903911000001101",
"source": "dmd",
"vtm_id": "36888211000001109",
"strength": "245 mg",
"substance": "Doravirine + Lamivudine + Tenofovir disoproxil",
"ingredient": "Tenofovir disoproxil",
"supplier_code": "39306911000001106"
}See everything about lamivudine, tenofovir disoproxil and doravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.